115027-08-2Relevant academic research and scientific papers
Substituted indole compound and method and use thereof
-
Paragraph 0287; 0289-0290, (2019/01/22)
The invention relates to a new indole compound, a drug composition which contains the new indole compound and a receptor for selectivity inhibiting 5-hydroxytryptamine reuptake and/or exciting 5-HT1A. The invention also relates to a method for preparing t
N-(INDOLETHYL-)CACLOAMINE COMPOUNDS
-
Page/Page column 22-23, (2008/06/13)
The invention relates to n-(indolethyl-)cacloamine compounds of a formula (i), wherein R1, R1 x, Ar and n have a meaning of the claim 1. The inventive compounds consist of inhibitors of serotonin recapture (SSRI) and activators of serotoninenergic receptors 5-HT1A and 5-HT2A. Said compounds are used for preventing and treating various diseases of the central nervous system such as depression, dyskenesia, Parkinson's disease, dementia, vascular cerebral accident, schizophrenia, Alzheimer disease, Lewy bodies dementia, Huntington disease, Gille de la Tourette syndrome, anxiety, learning difficulties, memory disorder, pain, insomnia and neurodegenerative diseases.
